TGFBR2 and hepatocellular carcinoma: AI-based analysis has also refined our tissue-based assessment of TGFBR2 in cirrhotic versus HCC tissue samples, demonstrating reduced TGFBR2 levels as a promising biomarker for HCC detection (Zaidi et al. 2022).